Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Personalized Medicine Is Closer Than You Think, FDA’s Throckmorton Says

Executive Summary

Personalized medicine should be adopted as a prospective strategy in drug development rather than primarily serving as a tool to salvage failing drug candidates, participants at FDA's Science Forum suggested

You may also be interested in...



AstraZeneca Personalized Medicine Team has 10 Projects In The Clinic - McHale

Duncan McHale joined the firm in May as personalized health care medical director.

Personalized Medicine Requires Specialized Clinical Trial Design – BIO Panel

To better establish personalized medicine as a practical strategy, sponsors should begin designing and conducting clinical trials with that goal in mind, speakers on a panel at the BIO International Convention recommend

Personalized Medicine Requires Specialized Clinical Trial Design – BIO Panel

To better establish personalized medicine as a practical strategy, sponsors should begin designing and conducting clinical trials with that goal in mind, speakers on a panel at the BIO International Convention recommend

Related Content

UsernamePublicRestriction

Register

OM013214

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel